D'Amato, V., Rosa, R., D'Amato, C., Formisano, L., Marciano, R., Nappi, L., . . . Bianco, R. (2014). The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models. Nature Publishing Group.
Chicago Style aipamenaD'Amato, V., et al. The Dual PI3K/mTOR Inhibitor PKI-587 Enhances Sensitivity to Cetuximab in EGFR-resistant Human Head and Neck Cancer Models. Nature Publishing Group, 2014.
MLA aipamenaD'Amato, V., et al. The Dual PI3K/mTOR Inhibitor PKI-587 Enhances Sensitivity to Cetuximab in EGFR-resistant Human Head and Neck Cancer Models. Nature Publishing Group, 2014.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.